138 related articles for article (PubMed ID: 10190732)
1. Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis.
Stanley AJ; Therapondos G; Helmy A; Hayes PC
J Hepatol; 1999 Mar; 30(3):479-84. PubMed ID: 10190732
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension.
Tripathi D; Therapondos G; Lui HF; Stanley AJ; Hayes PC
Aliment Pharmacol Ther; 2002 Mar; 16(3):373-80. PubMed ID: 11876689
[TBL] [Abstract][Full Text] [Related]
3. Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis.
Forrest EH; Bouchier IA; Hayes PC
J Hepatol; 1996 Dec; 25(6):909-15. PubMed ID: 9007720
[TBL] [Abstract][Full Text] [Related]
4. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
[TBL] [Abstract][Full Text] [Related]
5. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
Hobolth L; Bendtsen F; Hansen EF; Møller S
Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis.
Sugano S; Kawafune T; Suzuki T; Kubota M; Okajima T; Sumino Y; Akita H
Am J Gastroenterol; 1995 May; 90(5):788-93. PubMed ID: 7733089
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
8. Can intravenous beta blockade predict long-term haemodynamic benefit in chronic congestive heart failure secondary to ischaemic heart disease? A comparison between intravenous and oral carvedilol.
DasGupta P; Lahiri A
Clin Investig; 1992; 70 Suppl 1():S98-104. PubMed ID: 1350492
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
[TBL] [Abstract][Full Text] [Related]
10. The effects of carvedilol a nonselective beta-blocker on portal hemodynamics in cirrhosis.
Fierbinteanu-Braticevici C; Udeanu M; Dragomir P; Andronescu D
Rom J Intern Med; 2003; 41(3):247-54. PubMed ID: 15526508
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of one week of carvedilol administration on cirrhotic rats.
Lin HC; Huang YT; Wei HC; Yang YY; Lee TY; Wang YW; Hou MC; Lee SD
J Gastroenterol; 2006 Apr; 41(4):361-8. PubMed ID: 16741616
[TBL] [Abstract][Full Text] [Related]
12. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
Bañares R; Moitinho E; Matilla A; García-Pagán JC; Lampreave JL; Piera C; Abraldes JG; De Diego A; Albillos A; Bosch J
Hepatology; 2002 Dec; 36(6):1367-73. PubMed ID: 12447861
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension.
Eggertsen R; Sivertsson R; Andrén L; Hansson L
J Hypertens; 1984 Oct; 2(5):529-34. PubMed ID: 6152280
[TBL] [Abstract][Full Text] [Related]
15. Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients.
Eggertsen R; Andrén L; Sivertsson R; Hansson L
Eur J Clin Pharmacol; 1984; 27(1):19-22. PubMed ID: 6149128
[TBL] [Abstract][Full Text] [Related]
16. Effect of long-term carvedilol therapy on renal function in essential hypertension.
Tomita K; Marumo F
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S97-101. PubMed ID: 1378158
[TBL] [Abstract][Full Text] [Related]
17. Chronic haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.
Lund-Johansen P; Omvik P
Eur Heart J; 1992 Feb; 13(2):281-6. PubMed ID: 1555629
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol or propranolol in portal hypertension? A randomized comparison.
Hobolth L; Møller S; Grønbæk H; Roelsgaard K; Bendtsen F; Feldager Hansen E
Scand J Gastroenterol; 2012 Apr; 47(4):467-74. PubMed ID: 22401315
[TBL] [Abstract][Full Text] [Related]
19. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis.
Sinagra E; Perricone G; D'Amico M; Tinè F; D'Amico G
Aliment Pharmacol Ther; 2014 Mar; 39(6):557-68. PubMed ID: 24461301
[TBL] [Abstract][Full Text] [Related]
20. [The acute hemodynamic effects of the new vasodilating beta blocker carvedilol in comparison with combined administration of nifedipine and propranolol in patients with coronary heart disease].
Mauser M; Voelker W; Ickrath O; Hoffmeister HM; Karsch KR
Z Kardiol; 1989 Nov; 78(11):726-31. PubMed ID: 2609718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
